Activity of Gemcitabine and Continuous Infusion Fluorouracil in Advanced Pancreatic Cancer

Publisher： Karger

E-ISSN： 1423-0232|60|1|43-48

ISSN： 0030-2414

Source： Oncology, Vol.60, Iss.1, 2000-12, pp. : 43-48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Weekly Gemcitabine and 24-Hour Infusional 5-Fluorouracil in Advanced Pancreatic Cancer: A Phase I–II Study

By  

Oncology, Vol. 64, Iss. 2, 2003-02 ,pp. : 139-145

Karger

Access to resources Recommend Favorite

Irinotecan plus Gemcitabine and 5-Fluorouracil in Advanced Pancreatic Cancer: A Phase II Study

By  

Oncology, Vol. 72, Iss. 5-6, 2008-01 ,pp. : 279-284

Karger

Access to resources Recommend Favorite

Phase I Study of Hyperfractionated Radiation Therapy with Protracted 5-Fluorouracil Infusion in Patients with Locally Advanced Pancreatic Cancer

By  

Oncology, Vol. 67, Iss. 3-4, 2004-11 ,pp. : 215-221

Karger

Access to resources Recommend Favorite

Phase II Study of Cisplatin, Epirubicin, and Continuous-Infusion 5-Fluorouracil for Advanced Biliary Tract Cancer

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 475-476

Karger

Access to resources Recommend Favorite

Continuous Infusion of Oxaliplatin plus Chronomodulated Capecitabine in 5-Fluorouracil- and Irinotecan-Resistant Advanced Colorectal Cancer Patients

By  

Oncology, Vol. 69, Iss. 1, 2005-09 ,pp. : 27-34

Karger

Access to resources Recommend Favorite